Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription 13.04.2026 2 Ann Surg 2 Ann Surg Oncol 1 BMC Cancer 3 BMC Gastroenterol 1 BMJ Oncol 2 Br J Cancer 1 Cancer Lett 1 Clin Cancer Res 3 Eur J Cancer 5 Gastrointest Endosc 2 Gut 2 Int J Cancer 2 J Clin Oncol 3 J Natl Cancer Inst 1 J Surg Oncol 1 Oncol Rep 1 PLoS Genet 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. WILD C, Freeman JQ, Jamal A, Tiro J, et al
   Residing in a Food Desert is Associated with the Development of Colon Cancer Recurrence following Surgical Resection.
   Ann Surg. 2026 Apr 7. doi: 10.1097/SLA.0000000000007061.
   PubMed        
   
   
2. NUMATA M, Yamaguchi T, Shiomi A, Inada R, et al
   Prospective Multicenter Comprehensive Survey on Male Sexual Dysfunction following Laparoscopic, Robotic, and Transanal Approaches for Rectal Cancer (the LANDMARC Study).
   Ann Surg. 2026;283:869-877.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. CHINEN Y, Hata T, Takeda M, Sekido Y, et al
   ASO Visual Abstract: Clinical Significance of Bromodomain Containing Protein 9 in Colorectal Cancer.
   Ann Surg Oncol. 2026 Apr 8. doi: 10.1245/s10434-026-19524.
   PubMed        
   
   
4. MARTINEZ AE, Webber A, Davis L, Nigam A, et al
   ASO Visual Abstract: Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19603.
   PubMed        
   
   

   
   BMC Cancer

5. DU Z, Li DZ, Xu ZL, Li Q, et al
   Identification and verification of an eight-gene prognostic signature for colorectal cancer based on tumor-associated macrophages.
   BMC Cancer. 2026 Apr 6. doi: 10.1186/s12885-026-15965.
   PubMed        
   
   

   
   BMC Gastroenterol

6. SHINWARI H, Osama M, Nawaz AB, Khan M, et al
   Diabetes and socioeconomic status as key risk factors for colorectal cancer in the pashtun population: a case-control study.
   BMC Gastroenterol. 2026 Apr 9. doi: 10.1186/s12876-026-04759.
   PubMed        
   
   
7. CHEN Y, Deng S, Hakenberg P, Li C, et al
   DeepSeek-R1 vs. OpenAI o1 in colorectal cancer screening: a binational evaluation.
   BMC Gastroenterol. 2026;26:217.
   PubMed        
   
   
8. MASINA T, Chokotho L, Noah P, Mulwafu W, et al
   Evaluating clinicopathological pattern and management of colorectal cancer for adult patients presenting at Queen Elizabeth Central Hospital: a 10-year retrospective review.
   BMC Gastroenterol. 2026 Apr 7. doi: 10.1186/s12876-026-04800.
   PubMed        
   
   

   
   BMJ Oncol

9. GHOLAMI S, Saeed A, Baca Y, Hinton A, et al
   CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.
   BMJ Oncol. 2026;5:e001003.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. RAHKOLA O, Tuomisto A, Elomaa H, Karjalainen H, et al
    Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer.
    Br J Cancer. 2026 Apr 7. doi: 10.1038/s41416-026-03409.
    PubMed         Abstract available
    
    
11. HUISMANS MA, Gort EH, van der Heijden LT, Guven Mese SM, et al
    Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
    Br J Cancer. 2026 Apr 7. doi: 10.1038/s41416-026-03398.
    PubMed         Abstract available
    
    

    
    Cancer Lett

12. ZHENG Y, Liu H, Liu X, He W, et al
    The Therapeutic Landscape and Underlying Mechanisms of Taurine in Colorectal Cancer.
    Cancer Lett. 2026 Apr 7:218480. doi: 10.1016/j.canlet.2026.218480.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

13. AREF AT, Pathan M, Habib R, Hains PG, et al
    Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.
    Clin Cancer Res. 2026 Apr 9. doi: 10.1158/1078-0432.CCR-25-3200.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

14. AMBROSINI M, Gallois C, Gandini A, Lecanu A, et al
    From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer.
    Eur J Cancer. 2026;239:116731.
    PubMed         Abstract available
    
    
15. DERANGERE V, Lecuelle J, Lepage C, Salem OA, et al
    Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
    Eur J Cancer. 2026;239:116586.
    PubMed        
    
    
16. FOURNIER E, Schaffar R, Staehelin K, Rouxel N, et al
    Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021.
    Eur J Cancer. 2026;239:116707.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

17. CHANG PW, Nguyen DD, Kong N, Wang D, et al
    Impact of artificial intelligence-assisted colonoscopy on gastroenterology fellow performance: a pragmatic randomized controlled trial.
    Gastrointest Endosc. 2026;103:1043-1051.
    PubMed         Abstract available
    
    
18. TAGHIAKBARI M, Calce SI, Rex DK, Oleksiw M, et al
    Required withdrawal times to meet adenoma detection targets during colonoscopy.
    Gastrointest Endosc. 2026;103:1054-1063.
    PubMed         Abstract available
    
    
19. ELGENDY MS, Rifai M, Taha AM, Rajab I, et al
    Accuracy of Virtual Scale Endoscopy in colorectal polyp size measurement: a Grading of Recommendations Assessment, Development and Evaluation-assessed pairwise and network meta-analysis.
    Gastrointest Endosc. 2026;103:904-920.
    PubMed         Abstract available
    
    
20. TU W, Xu L
    Refining cost-effectiveness modeling of colorectal cancer screening in average-risk Asian populations: implications of risk-based stratification and free screening policies.
    Gastrointest Endosc. 2026;103:1100.
    PubMed        
    
    
21. SONG S, Liu C, Wan X
    Beyond resection with no residual microscopic disease: the critical role of histologic risk stratification in endoscopic management of suspected deep submucosal invasive colorectal cancer.
    Gastrointest Endosc. 2026;103:1101.
    PubMed        
    
    

    
    Gut

22. LI X, Xie M, Kang JX, Chen Y, et al
    Bifidobacterium catenulatum boosts anti-PD-1 efficacy in microsatellite stable colorectal cancer via activating CD8(+) T cells.
    Gut. 2026 Apr 9:gutjnl-2025-336025. doi: 10.1136/gutjnl-2025-336025.
    PubMed         Abstract available
    
    
23. LIU C, Gong J, Luo Z, Lai P, et al
    Gut microbe alleviates stress-related cancer metastasis by oleic acid degradation.
    Gut. 2026;75:968-983.
    PubMed         Abstract available
    
    

    
    Int J Cancer

24. LI X, Zhao Z, Stassen L, Maya AP, et al
    Head-to-head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection.
    Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70435.
    PubMed         Abstract available
    
    
25. SEUM T, Mandic M, Safizadeh F, Hoffmeister M, et al
    At what age should people with obesity start colorectal cancer screening?
    Int J Cancer. 2026 Apr 9. doi: 10.1002/ijc.70448.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

26. NOIRET B, Perez RO, Conroy T, Brown CJ, et al
    Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers.
    J Clin Oncol. 2026;44:1016-1027.
    PubMed         Abstract available
    
    
27. MEI WJ, Wang XZ, Zhang X, Sun YM, et al
    Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.
    J Clin Oncol. 2026;44:970-980.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

28. CAMPOY S, Drouet Y, Rochefort P, Bonadona V, et al
    Cancer risks in Lynch syndrome carriers: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2026;118:589-602.
    PubMed         Abstract available
    
    
29. CHIA BJ, Allegra C, Krishnamurthi S, Lieu C, et al
    A framework to evaluate surrogate endpoints at the trial level: Analysis in colorectal cancer.
    J Natl Cancer Inst. 2026 Mar 23:djag088. doi: 10.1093.
    PubMed         Abstract available
    
    
30. GAWDI R, Sjolander EN, Lee JS, Whelan RL, et al
    Evaluating the role of medicaid expansion on survival in early onset colorectal cancer.
    J Natl Cancer Inst. 2026 Apr 6:djag109. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

31. GEFEN R, Emile SH, Garoufalia Z, Dourado J, et al
    Radical Resection Compared to Local Excision for Very Old Patients With Stage 1 Rectal Cancer: An Exact-Match Analysis of the SEER Database.
    J Surg Oncol. 2026;133:563-571.
    PubMed         Abstract available
    
    

    
    Oncol Rep

32. NAKAJO S, Uemura M, Kusafuka H, Osaki M, et al
    Hypoxic CAF studies unveil PTHrP?vitamin D?RAS axis as pivotal in the CAF.
    Oncol Rep. 2026;55:109.
    PubMed         Abstract available
    
    

    
    PLoS Genet

33. KAFETZOPOULOS I, Taglini F, Pasquier M, Davidson-Smith H, et al
    DNMT1 loss leads to hypermethylation of a subset of late replicating domains by DNMT3A.
    PLoS Genet. 2026;22:e1012098.
    PubMed         Abstract available
    
    

    
    PLoS One

34. SANCHEZ MA, Mercier G, Clement MC, Ortega-Deballon P, et al
    Future impacts of colectomy healthcare pathways on quality of care in bundled payment experiments, a national retrospective cohort in France.
    PLoS One. 2026;21:e0346558.
    PubMed         Abstract available
    
    
35. CAI B, Lin B, Song C, Lu Z, et al
    Is there a "weekend effect" in adenoma detection rate?A single-center retrospective study.
    PLoS One. 2026;21:e0345613.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum